Schedule 13G ownership disclosure

IN8bio, Inc.

Common Stock · CUSIP: 45674E208

Event date: 2025-12-19

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Stonepine Capital Management, LLC

    Shares: 1,007,990.00 · Class: 9.9%

  • Stonepine Capital, L.P.

    Shares: 1,007,990.00 · Class: 9.9%

  • Stonepine GP, LLC

    Shares: 1,007,990.00 · Class: 9.9%

  • Jon M. Plexico

    Shares: 1,007,990.00 · Class: 9.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000935836-25-000732
Form type
SCHEDULE 13G
Filer
IN8BIO, INC.
CIK
CIK 1740279
Filed
Dec 22, 2025
Reporting period
Dec 19, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub